240 related articles for article (PubMed ID: 17353389)
1. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
Bacskai BJ; Frosch MP; Freeman SH; Raymond SB; Augustinack JC; Johnson KA; Irizarry MC; Klunk WE; Mathis CA; Dekosky ST; Greenberg SM; Hyman BT; Growdon JH
Arch Neurol; 2007 Mar; 64(3):431-4. PubMed ID: 17353389
[TBL] [Abstract][Full Text] [Related]
2. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
Shirvan J; Clement N; Ye R; Katz S; Schultz A; Johnson KA; Gomez-Isla T; Frosch M; Growdon JH; Gomperts SN
Neurology; 2019 Jul; 93(5):e476-e484. PubMed ID: 31243072
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Amyloid versus
Lesman-Segev OH; La Joie R; Iaccarino L; Lobach I; Rosen HJ; Seo SW; Janabi M; Baker SL; Edwards L; Pham J; Olichney J; Boxer A; Huang E; Gorno-Tempini M; DeCarli C; Hepker M; Hwang JL; Miller BL; Spina S; Grinberg LT; Seeley WW; Jagust WJ; Rabinovici GD
Ann Neurol; 2021 Feb; 89(2):389-401. PubMed ID: 33219525
[TBL] [Abstract][Full Text] [Related]
4. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Shea YF; Ha J; Lee SC; Chu LW
Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
[TBL] [Abstract][Full Text] [Related]
5. Antemortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies.
Kantarci K; Yang C; Schneider JA; Senjem ML; Reyes DA; Lowe VJ; Barnes LL; Aggarwal NT; Bennett DA; Smith GE; Petersen RC; Jack CR; Boeve BF
Neurobiol Aging; 2012 May; 33(5):878-85. PubMed ID: 20961664
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
[TBL] [Abstract][Full Text] [Related]
7. Amyloid imaging of Lewy body-associated disorders.
Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
[TBL] [Abstract][Full Text] [Related]
8. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
9. Practical utility of amyloid and FDG-PET in an academic dementia center.
Sánchez-Juan P; Ghosh PM; Hagen J; Gesierich B; Henry M; Grinberg LT; O'Neil JP; Janabi M; Huang EJ; Trojanowski JQ; Vinters HV; Gorno-Tempini M; Seeley WW; Boxer AL; Rosen HJ; Kramer JH; Miller BL; Jagust WJ; Rabinovici GD
Neurology; 2014 Jan; 82(3):230-8. PubMed ID: 24353340
[TBL] [Abstract][Full Text] [Related]
10. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
[TBL] [Abstract][Full Text] [Related]
11. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.
Burack MA; Hartlein J; Flores HP; Taylor-Reinwald L; Perlmutter JS; Cairns NJ
Neurology; 2010 Jan; 74(1):77-84. PubMed ID: 20038776
[TBL] [Abstract][Full Text] [Related]
12. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
13. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
Kantarci K; Lowe VJ; Chen Q; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Graff-Radford J; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Parisi JE; Dickson DW; Petersen RC; Boeve BF; Murray ME
Neurology; 2020 Jan; 94(3):e282-e291. PubMed ID: 31862783
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of brain amyloid in dementia: a review.
Quigley H; Colloby SJ; O'Brien JT
Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
[TBL] [Abstract][Full Text] [Related]
15. Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
Remes AM; Laru L; Tuominen H; Aalto S; Kemppainen N; Mononen H; Någren K; Parkkola R; Rinne JO
Arch Neurol; 2008 Apr; 65(4):540-4. PubMed ID: 18413480
[TBL] [Abstract][Full Text] [Related]
16. [11C]PIB binding in Parkinson's disease dementia.
Maetzler W; Reimold M; Liepelt I; Solbach C; Leyhe T; Schweitzer K; Eschweiler GW; Mittelbronn M; Gaenslen A; Uebele M; Reischl G; Gasser T; Machulla HJ; Bares R; Berg D
Neuroimage; 2008 Feb; 39(3):1027-33. PubMed ID: 18035558
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of Pittsburgh compound-B-negative dementia.
Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
[TBL] [Abstract][Full Text] [Related]
18. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.
Ikonomovic MD; Abrahamson EE; Price JC; Hamilton RL; Mathis CA; Paljug WR; Debnath ML; Cohen AD; Mizukami K; DeKosky ST; Lopez OL; Klunk WE
Acta Neuropathol; 2012 Mar; 123(3):433-47. PubMed ID: 22271153
[TBL] [Abstract][Full Text] [Related]
19. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.
LeVine H; Spielmann HP; Matveev S; Cauvi FM; Murphy MP; Beckett TL; McCarty K; Lott IT; Doran E; Schmitt F; Head E
Neurobiol Aging; 2017 Jun; 54():163-169. PubMed ID: 28385551
[TBL] [Abstract][Full Text] [Related]
20. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
Ng SY; Villemagne VL; Masters CL; Rowe CC
Arch Neurol; 2007 Aug; 64(8):1140-4. PubMed ID: 17698704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
